Cell-Specific In Vivo Gene Delivery & Genome Editing via Retargetable Fusogens
Time: 9:30 am
day: Day 2
Details:
• Highlight the in vivo delivery platform that Sana has developed for gene therapy
• Discuss progress in targeting T Cells and HSCs
• Provide examples of pre-clinical studies with delivery of integrating vectors and Gene editing machinery
